CA-125	Cancer antigen 125
FIA	Flow injection analysis
OC	Ovarian cancer
HC	Healthy control
LOD	Limit of determination
AC	Acylcarnitines
DC	Diglycerides
LPS	Lysophosphatidylcholines
PC	Phosphatidylcholines
SM	Sphingomyelins
DAM	Differential abundant plasma metabolite
ROC	Receiver operating characteristic
AUC	Area under the curve
LFQ	Label free quantification
PCA	Principle component analysis
DAP	Differential abundant plasma protein
IGF	Insulin-like growth factor
IPA	Ingenuity pathway analysis
HIF-1	Hypoxia-inducible factor 1
DIABLO	Data Integration Analysis and Biomarker discovery using Latent cOmponents
KM	Kaplan–Meier
OS	Overall survival
DFS	Disease-free survival
PPCS	Phosphopantothenate–cysteine ligase
PMP2	Myelin P2 protein
TUBB	Tubulin beta chain
AC.0.0	L-carnitine
HR	Hazard ratio
ESI-LC–MS/MS	Electrospray ionization liquid chromatography–tandem mass spectrometry
FIA–MS/MS	Flow injection analysis–tandem mass spectrometry
MARS14	Multiple Affinity Removal Column Human 14
m/z	Mass to charge ratio